고지사항: 이 페이지에는 제휴 링크가 포함될 수 있습니다. 귀하가 제휴사 링크를 방문하고 이러한 제휴 플랫폼에서 회원 가입 및 거래와 같은 특정 행동을 취하는 경우 CoinMarketCap은 이에 대해 보상받을 수 있습니다. 더 자세한 내용은 제휴 관련 고지에서 확인해 주세요.
Triall 뉴스
Triall 정보
What is Triall (TRL)?
Triall is an end-to-end digital ecosystem of blockchain-enabled software solutions for clinical trials.
The project leverages blockchain, Artificial Intelligence, and related technologies to make clinical trial processes tamper-resistant, and to enable secure and compliant connections between the many isolated systems and parties involved in clinical research.
Triall’s native TRL token enables access to ecosystem utilities, P2P compensation, governance, and community engagement.
The project is on a mission to accelerate the introduction of safe and affordable new vaccines and therapeutics into society by streamlining clinical trial operations.
Who are the founders of TRL?
Triall was founded by a group of clinical operations experts, enterprise IT specialists, and blockchain developers.
Combined, their team has managed 100+ clinical trials, co-founded 20+ business ventures, and published 250+ peer-reviewed papers on innovation in medical research. This experience has left Triall with an extensive network within clinical research and the Life Sciences at large.
Triall has built an international network of partners and a global advisory board consisting of industry experts and Key Opinion Leaders that support the project in the buildout of its blockchain-enabled ecosystem.
What makes Triall unique?
As frontrunner in the clinical trials industry, Triall applies blockchain technology to address two industry-wide needs: (1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and (2) enabling secure and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling the growing problem of data fragmentation.
Triall takes an ‘ecosystem approach’ that is unique to the clinical trials industry: by enabling secure and compliant integrations between currently isolated clinical trial software, the project aims to turn current competitors into cooperators for the benefit of faster and more-efficient clinical trials. To this end, the project leverages emerging open blockchain standards such as Decentralized Identifiers (DIDs) and Verifiable Credentials (VCs). These will shape a decentralized identity and access management infrastructure for connecting systems and their users in a secure environment.
오늘의 Triall 실시간 가격은 ₩5.71 KRW이며 24시간 거래량은 ₩789,368 KRW입니다. TRL 대 KRW 가격을 실시간으로 업데이트합니다. Triall은(는) 지난 24시간 동안 6.73 하락했습니다. 현재 코인마켓캡 순위는 #2112위이며, 실시가총액은 ₩241,973,815 KRW입니다. 순환 공급량은 42,365,415 TRL코인입니다 및 최대 공급량은 175,000,000 TRL코인입니다.